Stories

Eczema drug shows promise in clinical trials

Eczema drug shows promise in clinical trials

By Elisa Williams March 08, 2017
A drug that works by targeting and blocking some of the body’s chemical messengers, which can become overactive in allergic reactions, shows promise in reducing symptoms caused by a severe form of eczema.
The OHSU Knight – Legacy Health Cancer Collaborative program expands to Clark County

The OHSU Knight – Legacy Health Cancer Collaborative program expands to Clark County

By Amanda Gibbs March 02, 2017
The OHSU Knight Cancer Institute and Legacy Health have signed business agreements with The Vancouver Clinic, or TVC, to expand their network of integrated adult cancer care clinics to southwest Washington. The agreement is the latest addition to the OHSU Knight-Legacy Health Cancer Collaborative, established in 2013.

Updated preventive health recommendations a win for women nationwide

By Ariane Le Chevallier February 22, 2017
Physicians in the Pacific Northwest Evidence-based Practice Center at OHSU in Portland, Oregon, played a critical role in updating recommendations for the Women’s Preventive Services Guidelines, which address a wide variety of unique health issues women face.
Gene mutations cause leukemia, but which ones?

Gene mutations cause leukemia, but which ones?

By Amanda Gibbs February 21, 2017
Research published today in the journal Oncotarget, sought to better understand one “typo” in a standard leukemia assay, or test. While studying cancer biology and completing his doctorate at the OHSU Knight Cancer Institute, Kevin Watanabe-Smith, Ph.D., encountered a new problem: an issue with the model system itself.
See more stories